1-2 of 2
Mike Hamblin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route

Brief Report
Claire E. Dearden, Amit Khot, Monica Else, Mike Hamblin, Effie Grand, Ashok Roy, Saman Hewamana, Estella Matutes, Daniel Catovsky
Journal: Blood
Blood (2011) 118 (22): 5799–5802.
https://doi.org/10.1182/blood-2011-08-372854
Published: 2011
Journal Articles

Alemtuzumab Administered by Subcutaneous Route Is Less Effective Than Intravenous Route for First Line Therapy of T-Cell Prolymphocytic Leukaemia: Results of a Pilot Study (UKCLL05)

Ami t S Khot, Estella Matutes, MD, PhD, Pawel A Kaczmarek, Mike Hamblin, Ashok Roy, Effie Grand, Mark E Ethell, Claire E Dearden, MD
Journal: Blood
Blood (2008) 112 (11): 4204.
https://doi.org/10.1182/blood.V112.11.4204.4204
Published: 2008